Thyrocare

  • Revenue₹58.9 MFY, 2022
  • Market Capitalization₹33 B2022-06-29

OverviewSuggest Edit

Thyrocare Technologies is an automated diagnostic laboratory. The company offers medical diagnostic tests that focus on early detection and management of metabolic disorders and other diseases, including thyroid, diabetes, anemia, arthritis, cancer, infertility, and etc. It serves patients, laboratories, and hospitals using IT enabled, barcoded, bidirectional system for processing samples.
TypePublic
Founded1996
HQNavi Mumbai, INMap
Websitethyrocare.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Mar 2021)1,582(+19%)
Revenue (FY, 2022)₹58.9 M(-98%)
Share Price (Jun 2022)₹626
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Thyrocare

Rahul Franklin Guha

Rahul Franklin Guha

Managing Director and CEO
Dharmil Nirupam

Dharmil Nirupam

Non-executive Director
Hardik Dedhia

Hardik Dedhia

Non-executive Director
Dhaval Rajesh Shah

Dhaval Rajesh Shah

Non-executive Director
Gopal Shivram Hegde

Gopal Shivram Hegde

Independent Director
Vishwas Madhav Kulkarni

Vishwas Madhav Kulkarni

Independent Director
Show more

Thyrocare Office Locations

Thyrocare has offices in Navi Mumbai, Al Hidd, Dhaka and Kathmandu
Navi Mumbai, IN (HQ)
37, 1, MIDC Main Rd, Indira Nagar, MIDC Industrial Area, Turbhe
Al Hidd, BH
43, Bldg No.737, Road 1510, BIIP, Block 115
Dhaka, BD
12th floor, Confidence Center, 01 Bayzid Rd
Kathmandu, NP
Lazimpat
Show all (4)

Thyrocare Financials and Metrics

Thyrocare Revenue

Thyrocare's revenue was reported to be ₹58.89 m in FY, 2022
INR

Revenue (FY, 2022)

58.9m

Gross profit (FY, 2022)

44.8m

Net income (FY, 2022)

17.6m

EBITDA (FY, 2022)

26.4m

EBIT (FY, 2022)

23.0m

Market capitalization (29-Jun-2022)

33.0b

Closing stock price (29-Jun-2022)

626.0

Cash (31-Mar-2022)

1.4m

EV

33.0b
Thyrocare's current market capitalization is ₹33 b.
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022

Revenue

3.5b4.0b4.3b4.9b58.9m

Cost of goods sold

(949.8m)(1.1b)(1.2b)(1.6b)(17.0m)

Gross profit

2.8b3.0b3.2b3.3b44.8m
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Revenue

971.5m1.0b962.9m1.1b1.2b1.1b562.7m1.5b1.4b1.6b1.8b1.2b

Cost of goods sold

(256.0m)(283.7m)(259.5m)(308.6m)(312.1m)(275.0m)(259.6m)(508.5m)(427.0m)(542.2m)(436.1m)(300.0m)

Gross profit

738.1m779.1m736.8m812.3m874.9m791.4m315.3m1.1b981.5m1.2b1.5b888.0m
show all
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022

Cash

118.6m96.0m110.7m157.3m1.4m

Accounts Receivable

98.4m121.6m165.6m446.8m9.3m

Prepaid Expenses

34.6m24.8m9.7m12.4m

Inventories

170.5m180.8m206.2m233.6m2.5m
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Cash

557.5m258.8m90.2m64.6m77.0m

Accounts Receivable

129.8m162.3m380.6m1.1b1.1b

Inventories

219.5m231.8m269.9m213.2m212.0m
show all
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022

Net Income

1.4b1.4b1.5b1.5b22.8m

Depreciation and Amortization

201.0m261.7m265.8m251.4m3.4m

Inventories

(25.6m)(10.3m)(25.4m)(27.4m)(117.0k)

Accounts Payable

(1.3m)9.1m143.5m31.5m(848.0k)
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Net Income

863.7m612.9m1.7b

Depreciation and Amortization

155.8m146.1m154.5m

Inventories

(51.0m)(63.6m)20.4m

Accounts Payable

10.7m(5.5m)(70.0m)
show all
Show all financial metrics

Thyrocare Revenue Breakdown

Embed Graph

Thyrocare revenue breakdown by business segment: 94.3% from DIAGNOSTIC TESTING SERVICES and 5.7% from Other

Thyrocare revenue breakdown by geographic segment: 100.0% from INDIA

Thyrocare Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

Learn more about our premium products
SecurityScorecard logo

Thyrocare Online and Social Media Presence

Thyrocare's Trends

Embed Graph

Thyrocare News and Updates

June 26, 2021

PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crore

Online pharmacy startup PharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies as it looks to diversify and bolster its testing business. PharmEasy parent API Holdings signed a definitive agreement to acquire a 66.1% stake in Thyrocare for Rs 4,546 crore, according to an…

 Thyrocare Frequently Asked Questions

  • When was Thyrocare founded?

    Thyrocare was founded in 1996.

  • Who are Thyrocare key executives?

    Thyrocare's key executives are Rahul Franklin Guha, Dharmil Nirupam and Hardik Dedhia.

  • How many employees does Thyrocare have?

    Thyrocare has 1,582 employees.

  • What is Thyrocare revenue?

    Latest Thyrocare annual revenue is ₹58.9 m.

  • What is Thyrocare revenue per employee?

    Latest Thyrocare revenue per employee is ₹37.2 k.

  • Who are Thyrocare competitors?

    Competitors of Thyrocare include Aegis Sciences, Prevent Senior and Chughtai Lab.

  • Where is Thyrocare headquarters?

    Thyrocare headquarters is located at 37, 1, MIDC Main Rd, Indira Nagar, MIDC Industrial Area, Turbhe, Navi Mumbai.

  • Where are Thyrocare offices?

    Thyrocare has offices in Navi Mumbai, Al Hidd, Dhaka and Kathmandu.

  • How many offices does Thyrocare have?

    Thyrocare has 4 offices.